112859-71-9

112859-71-9 structure

Name: HE-2500
Chemical Name: Fluasterone
CAS Number: 112859-71-9
Molecular Formula: C₁₉H₂₇FO
Molecular Weight: 290.42
Catalog: Research Areas Cancer
Create Date: 2016-07-05 06:44:39
Modify Date: 2025-08-25 16:30:20
Fluasterone is a potent G6PD inhibitor with a Ki of 0.51 μM. Fluasterone has anti-inflammatory, cancer preventive, and anti-diabetic effects. Fluasterone is orally active[1][2][3].

Name	Fluasterone
Synonyms	16-fluoro-5-androsten-17-one

Description	Fluasterone is a potent G6PD inhibitor with a Ki of 0.51 μM. Fluasterone has anti-inflammatory, cancer preventive, and anti-diabetic effects. Fluasterone is orally active[1][2][3].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology Research Areas >> Metabolic Disease
Target	Ki: 0.51 μM (G6PD)[3]
In Vivo	Fluasterone (0.2% and 0.3%; in diet for 39 days) 对糖尿病小鼠有抗高血糖作用[2]。 Fluasterone (200 μg/mouse; intradermal injection; once) 抑制 TPA 诱导的急性炎症和表皮增生作用[3]。 Animal Model: Male C57BL/KsJ db/db mice, diabetic model[2] Dosage: 0.2% and 0.3% Administration: In the diet for 39 days Result: Markedly reduced plasma glucose levels.
References	[1]. Schwartz AG, et al. Potential therapeutic use of dehydroepiandrosterone and structural analogs. Diabetes Technol Ther. 2001 Summer;3(2):221-4. [2]. Pashko LL, et al. Antihyperglycemic effect of dehydroepiandrosterone analogue 16 alpha-fluoro-5-androsten-17-one in diabetic mice. Diabetes. 1993 Aug;42(8):1105-8. [3]. Schwartz AG, et al. Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia and inflammation by the dehydroepiandrosterone analog 16alpha-fluoro-5-androsten-17-one and its reversal by NADPH liposomes. Cancer Lett. 2001 Jul 10;168(1):7-14.